Acurx Pharmaceuticals Inc... (ACXP)
undefined
undefined%
At close: undefined
0.86
1.08%
After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue - - - - -
Cost of Revenue - - - - -
Gross Profit - - - - -
Operating Income -14.58M -12.09M -12.88M -4.60M -5.93M
Interest Income - - - - -
Pretax Income -14.58M -12.09M -12.75M -4.60M -5.93M
Net Income -14.58M -12.09M -12.68M -4.60M -5.93M
Selling & General & Admin 8.53M 7.34M 10.78M 2.40M 2.42M
Research & Development 6.04M 4.75M 2.03M 2.20M 3.51M
Other Expenses - - - - -
Operating Expenses 14.58M 12.09M 12.81M 4.60M 5.93M
Interest Expense - - - - -
Selling & Marketing Expenses - - - - -
Cost & Expenses 14.58M 12.09M 12.81M 4.60M 5.93M
Income Tax - -1.22K -66.50K -4.60K -5.93K
Shares Outstanding (Basic) 12.67M 10.82M 10.22M 9.92M 9.92M
Shares Outstanding (Diluted) 12.67M 10.82M 10.22M 9.92M 9.92M
EPS (Basic) -1.15 -1.12 -1.24 -0.46 -0.6
EPS (Diluted) -1.15 -1.12 -1.24 -0.46 -0.6
EBITDA - -12.09M - -4.60M -5.93M
Depreciation & Amortization 14.58M 12.09M 12.81M 4.60M 5.93M